OTCMKTS:ONPH Oncology Pharma (ONPH) Stock Price, News & Analysis $0.04 -0.01 (-18.18%) As of 11/13/2026 01:19 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChart About Oncology Pharma Stock (OTCMKTS:ONPH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Oncology Pharma alerts:Sign Up Key Stats Today's Range$0.04▼$0.0450-Day Range$0.03▼$0.0752-Week Range$0.00▼$0.36Volume125,258 shsAverage Volume10,335 shsMarket Capitalization$1.39 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Oncology Pharma, Inc. (OTCMKTS:ONPH) is a development-stage pharmaceutical company focused on oncology-related products and therapies. Publicly available information about its specific product portfolio, commercial operations and research programs is limited. The company has been associated with the development and potential commercialization of treatments intended for cancer patients, but detailed information about approved products, clinical programs, distribution channels and geographic markets is not readily available from reliable public sources. Because the company’s current operating activities and leadership information are limited in public filings and other readily verifiable sources, investors should review the company’s latest disclosures for updates regarding its strategy, partnerships and business status.AI Generated. May Contain Errors. Read More Receive ONPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oncology Pharma and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ONPH Stock News HeadlinesOncology Pharma (OTCMKTS:ONPH) Share Price Crosses Above 200 Day Moving Average - Time to Sell?November 4, 2026 | americanbankingnews.comOncology Pharma Inc.April 1, 2026 | barrons.comFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leading Weiss Ratings, the only conflict-free rating agency in the US. Now he says a $3 trillion problem could trigger a chain reaction of crashes and failures, causing a global freeze in financial markets.November 14 at 1:00 AM | Weiss Ratings (Ad)Innate Pharma’s IPH4502: A Promising Step in Cancer TreatmentOctober 28, 2025 | msn.comRoyalty Pharma to buy royalty interest in Amgen’s Imdelltra for up to $950MAugust 25, 2025 | msn.comBeOne Sells Cancer Drug Royalty Rights to Royalty PharmaAugust 25, 2025 | marketwatch.comRoyalty Pharma to pay up to $950 million for royalties from Amgen's lung cancer drugAugust 25, 2025 | msn.comVenture Capital Investment Trends in Pharma Q2 2025 | 115 Investors Back 53 Oncology Deals in Q2 2025's Pharma SectorAugust 21, 2025 | finance.yahoo.comSee More Headlines ONPH Stock Analysis - Frequently Asked Questions How have ONPH shares performed this year? Oncology Pharma's stock was trading at $0.0040 at the beginning of 2026. Since then, ONPH stock has increased by 800.0% and is now trading at $0.0360. How do I buy shares of Oncology Pharma? Shares of ONPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Oncology Pharma own? Based on aggregate information from My MarketBeat watchlists, some other companies that Oncology Pharma investors own include Ford Motor (F), NVIDIA (NVDA), Advanced Micro Devices (AMD), SoFi Technologies (SOFI), Tesla (TSLA), Intel (INTC) and Shopify (SHOP). Company Calendar Today11/14/2026Fiscal Year End3/31/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:ONPH CIKN/A Webwww.oncology-pharma.com Phone(415) 869-1038Fax858-385-8997Employees1Year Founded1993Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares38,660,000Free Float31,704,000Market Cap$1.39 million OptionableNot Optionable Beta-5.13 7 Blue-Chip Stocks to Add To Your Forever PortfolioA strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership. This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.Get This Free Report This page (OTCMKTS:ONPH) was last updated on 11/13/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredExecutive Order 14241 Unleashes Trump’s New DollarA landmark executive order, 14241, is reportedly set to reshape how Americans use money starting this December...Porter & Company | SponsoredLog into Keith’s $5,000 AI Signals Trading system todayA new AI system from the TradeSmith Daily team shows trades taking shape 90 minutes before they occur, with 93...TradeSmith | SponsoredElon wants to move AI off the planet. Amazon isn't ready.What if the next AI race isn't on Earth? Tim Bohen's Mission X presentation explores Elon Musk's idea of movin...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncology Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncology Pharma With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
